[et_pb_section fb_built=”1″ _builder_version=”4.23.3″ _module_preset=”default” custom_padding=”0px||0px|||” global_colors_info=”{}” theme_builder_area=”post_content”][et_pb_row _builder_version=”4.23.3″ _module_preset=”default” global_colors_info=”{}” theme_builder_area=”post_content”][et_pb_column type=”4_4″ _builder_version=”4.23.3″ _module_preset=”default” global_colors_info=”{}” theme_builder_area=”post_content”][et_pb_text _builder_version=”4.27.5″ _module_preset=”default” min_height=”348.8px” hover_enabled=”0″ global_colors_info=”{}” theme_builder_area=”post_content” sticky_enabled=”0″]<\/p>\n
We\u2019re thrilled to share that<\/span> <\/span>Alexander Rotenberg<\/span> <\/span>of the Kirby Neurobiology Center and<\/span> <\/span>Boston Children’s Hospital<\/span> <\/span>has been named a 2025 Harrington Scholar-Innovator by the<\/span> <\/span>Harrington Discovery Institute at University Hospitals!<\/span> [\/et_pb_text][\/et_pb_column][\/et_pb_row][et_pb_row _builder_version=”4.23.3″ _module_preset=”default” global_colors_info=”{}” theme_builder_area=”post_content”][et_pb_column type=”4_4″ _builder_version=”4.23.3″ _module_preset=”default” global_colors_info=”{}” theme_builder_area=”post_content”][et_pb_image src=”https:\/\/epitomestaging.com\/kirby\/wp-content\/uploads\/2025\/12\/1749043227297.jpg” title_text=”1749043227297″ _builder_version=”4.27.5″ _module_preset=”default” hover_enabled=”0″ global_colors_info=”{}” theme_builder_area=”post_content” sticky_enabled=”0″][\/et_pb_image][\/et_pb_column][\/et_pb_row][\/et_pb_section]<\/p>\n","protected":false},"excerpt":{"rendered":" We\u2019re thrilled to share that Alexander Rotenberg of the Kirby Neurobiology Center and Boston Children’s Hospital has been named a 2025 Harrington Scholar-Innovator by the Harrington Discovery Institute at University Hospitals!Dr. Rotenberg’s project is titled \u201cGene therapy for a rare inherited disease, Succinic Semialdehyde Dehydrogenase Deficiency (SSADHD).\u201d SSADHD is a rare pediatric neurometabolic disorder with […]<\/p>\n","protected":false},"author":11,"featured_media":1028,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_et_pb_use_builder":"on","_et_pb_old_content":"","_et_gb_content_width":"","_monsterinsights_skip_tracking":false,"_monsterinsights_sitenote_active":false,"_monsterinsights_sitenote_note":"","_monsterinsights_sitenote_category":0,"footnotes":""},"categories":[24],"tags":[],"class_list":["post-7474","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-in-the-media"],"_links":{"self":[{"href":"https:\/\/epitomestaging.com\/kirby\/wp-json\/wp\/v2\/posts\/7474","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/epitomestaging.com\/kirby\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/epitomestaging.com\/kirby\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/epitomestaging.com\/kirby\/wp-json\/wp\/v2\/users\/11"}],"replies":[{"embeddable":true,"href":"https:\/\/epitomestaging.com\/kirby\/wp-json\/wp\/v2\/comments?post=7474"}],"version-history":[{"count":2,"href":"https:\/\/epitomestaging.com\/kirby\/wp-json\/wp\/v2\/posts\/7474\/revisions"}],"predecessor-version":[{"id":7478,"href":"https:\/\/epitomestaging.com\/kirby\/wp-json\/wp\/v2\/posts\/7474\/revisions\/7478"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/epitomestaging.com\/kirby\/wp-json\/wp\/v2\/media\/1028"}],"wp:attachment":[{"href":"https:\/\/epitomestaging.com\/kirby\/wp-json\/wp\/v2\/media?parent=7474"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/epitomestaging.com\/kirby\/wp-json\/wp\/v2\/categories?post=7474"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/epitomestaging.com\/kirby\/wp-json\/wp\/v2\/tags?post=7474"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}
<\/span>
<\/span>Dr. Rotenberg’s project is titled \u201cGene therapy for a rare inherited disease, Succinic Semialdehyde Dehydrogenase Deficiency (SSADHD).\u201d<\/span>
<\/span>
<\/span> <\/span>SSADHD is a rare pediatric neurometabolic disorder with no approved treatments\u2014and Dr. Rotenberg\u2019s groundbreaking work is aiming to change that through targeted gene therapy.<\/span>
<\/span>
<\/span>This prestigious award supports physician-scientists advancing breakthrough treatments from bench to bedside. Dr. Rotenberg\u2019s recognition is a powerful testament to his visionary science, relentless dedication, and commitment to families facing rare and often overlooked neurological diseases.<\/span>
<\/span>
<\/span>We\u2019re incredibly proud to celebrate this honor with him and look forward to the impact his work will have on children and families around the world.<\/span><\/p>\n